148 related articles for article (PubMed ID: 7942778)
1. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats.
Aoki Y; Takei R; Mohri M; Gonda Y; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Am J Hematol; 1994 Nov; 47(3):162-6. PubMed ID: 7942778
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis.
Ono M; Nawa K; Marumoto Y
Thromb Haemost; 1994 Sep; 72(3):421-5. PubMed ID: 7855794
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
6. Effects of human soluble thrombomodulin on experimental glomerulonephritis.
Ikeguchi H; Maruyama S; Morita Y; Fujita Y; Kato T; Natori Y; Akatsu H; Campbell W; Okada N; Okada H; Yuzawa Y; Matsuo S
Kidney Int; 2002 Feb; 61(2):490-501. PubMed ID: 11849389
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
[TBL] [Abstract][Full Text] [Related]
8. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
Sato K; Kawasaki T; Hisamichi N; Taniuchi Y; Hirayama F; Koshio H; Matsumoto Y
Br J Pharmacol; 1998 Jan; 123(1):92-6. PubMed ID: 9484858
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
Berry CN; Girard D; Lochot S; Lecoffre C
Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
[TBL] [Abstract][Full Text] [Related]
11. Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats.
Mohri M; Oka M; Aoki Y; Gonda Y; Hirata S; Gomi K; Kiyota T; Sugihara T; Yamamoto S; Ishida T
Am J Hematol; 1994 Apr; 45(4):298-303. PubMed ID: 8178801
[TBL] [Abstract][Full Text] [Related]
12. Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat model.
Solis MM; Cook C; Cook J; Glaser C; Light D; Morser J; Yu SC; Fink L; Eidt JF
J Vasc Surg; 1991 Nov; 14(5):599-604. PubMed ID: 1658403
[TBL] [Abstract][Full Text] [Related]
13. Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
Rukshin V; Azarbal B; Finkelstein A; Shah PK; Cercek B; Tsang V; Kaul S
J Cardiovasc Pharmacol; 2003 Apr; 41(4):615-24. PubMed ID: 12658064
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity.
Sugidachi A; Asai F; Koike H
Thromb Res; 1993 Jan; 69(1):71-80. PubMed ID: 8465276
[TBL] [Abstract][Full Text] [Related]
15. Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
Rukshin V; Shah PK; Cercek B; Finkelstein A; Tsang V; Kaul S
Circulation; 2002 Apr; 105(16):1970-5. PubMed ID: 11997285
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
Morishima Y; Honda Y; Kamisato C; Shibano T
Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
[TBL] [Abstract][Full Text] [Related]
17. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation.
Uchiba M; Okajima K; Murakami K; Johno M; Mohri M; Okabe H; Takatsuki K
Am J Physiol; 1997 Oct; 273(4):L889-94. PubMed ID: 9357866
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Pehrsson S; Johansson K; Kjaer M; Elg M
Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
[TBL] [Abstract][Full Text] [Related]
19. A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivo.
Refino CJ; Himber J; Burcklen L; Moran P; Peek M; Suggett S; Devaux B; Kirchhofer D
Thromb Haemost; 1999 Sep; 82(3):1188-95. PubMed ID: 10494786
[TBL] [Abstract][Full Text] [Related]
20. Recombinant soluble human thrombomodulin: a randomized, blinded assessment of prevention of venous thrombosis and effects on hemostatic parameters in a rat model.
Solis MM; Vitti M; Cook J; Young D; Glaser C; Light D; Morser J; Wydro R; Yu S; Fink L
Thromb Res; 1994 Mar; 73(6):385-94. PubMed ID: 8073391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
